Large-scale testing (Phase 3)Study completedNCT00001757
What this trial is testing
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
Who this might be right for
Mycoses
National Institute of Allergy and Infectious Diseases (NIAID) 20